Cargando…
Analytical methods for process and product characterization of recombinant adeno-associated virus-based gene therapies
The optimization of upstream and downstream processes for production of recombinant adeno-associated virus (rAAV) with consistent quality depends on the ability to rapidly characterize critical quality attributes (CQAs). In the context of rAAV production, the virus titer, capsid content, and aggrega...
Autores principales: | Gimpel, Andreas L., Katsikis, Georgios, Sha, Sha, Maloney, Andrew John, Hong, Moo Sun, Nguyen, Tam N.T., Wolfrum, Jacqueline, Springs, Stacy L., Sinskey, Anthony J., Manalis, Scott R., Barone, Paul W., Braatz, Richard D. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Society of Gene & Cell Therapy
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7940698/ https://www.ncbi.nlm.nih.gov/pubmed/33738328 http://dx.doi.org/10.1016/j.omtm.2021.02.010 |
Ejemplares similares
-
Mechanistic model for production of recombinant adeno-associated virus via triple transfection of HEK293 cells
por: Nguyen, Tam N.T., et al.
Publicado: (2021) -
Mechanistic modeling explains the production dynamics of recombinant adeno-associated virus with the baculovirus expression vector system
por: Destro, Francesco, et al.
Publicado: (2023) -
Models to inform neutralizing antibody therapy strategies during pandemics: the case of SARS-CoV-2
por: Guttieres, Donovan, et al.
Publicado: (2021) -
Cyberbiosecurity in Advanced Manufacturing Models
por: Guttieres, Donovan, et al.
Publicado: (2019) -
Stronger together: Analytical techniques for recombinant adeno associated virus
por: Hutanu, Andrei, et al.
Publicado: (2021)